E-Book | March 31, 2020

Cold Chain Industry Trends - Planning Tips To Create A Robust Supply Chain

Source: Thermo Fisher Scientific
FSC

The maintenance of cold chain product integrity across the entire supply chain demands rigorous processes and cold chain expertise of the highest caliber—from packaging, handling, storage & distribution of temperature sensitive Investigational Medicinal Products (IMP), all the way to the investigator site. This eBook provides an industry overview and a framework for discussion. The importance of a robust supply chain is addressed. It includes planning recommendations for biopharmaceutical companies preparing to scale up to global vaccine trials.

Industry Trends

‘Cold chain management’ is undoubtedly a hot topic in the clinical research industry because a rising percentage of the drugs in clinical testing today are biologics. The percentage of pharmaceuticals based on biologics and vaccines has grown tremendously in the past decade. With hundreds of vaccines in research and development worldwide, vaccines are among the fastest growing segments of the biopharmaceutical market today. In 2016, biologics accounted for six of the top-eight drugs, in terms of revenue. In fact, the global biologics market size is expected to reach around $319 billion by 2021 at an annual growth rate of 9.6%, more than twice the growth rate of conventional pharmaceuticals.

New drug development is accompanied by formidable challenges, both for biopharmaceutical research companies pursuing the next generation of products, as well as the clinical supply chain partners. These partners often take responsibility for packaging, labeling, storing and delivering IMP for global clinical trials. In addition to their cost and complexity to develop and manufacture, vaccines must be stored, transported and maintained at controlled temperatures in a “cold chain environment.” Maintaining cold supply chain demands planning, partnering and attention to detail; a single broken link can result in loss of scarce resources and time, the twin currencies of the biopharmaceutical industry.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene